PF4 and Thrombocytopenia: According to one study, five patients infected by venous thrombosis and thrombocytopenia 7–10 days after injecting the first AstraZeneca dose of adenoviral vector vaccine showed significant levels of antibodies to platelet factor 4-poly-anion complexes, without any prior heparin exposure.